Systematic review of natural agents for the management of oral mucositis in cancer patients

被引：0
作者：
Noam Yarom
Anura Ariyawardana
Allan Hovan
Andrei Barasch
Virginia Jarvis
Siri Beier Jensen
Yehuda Zadik
Sharon Elad
Joanne Bowen
Rajesh V. Lalla
机构：
[1] Sheba Medical Center,Department of Oral and Maxillofacial Surgery
[2] Tel-Aviv University,Department of Oral Pathology and Oral Medicine, School of Dental Medicine
[3] James Cook University,School of Medicine and Dentistry
[4] Griffith University,Griffith Health Institute
[5] BC Cancer Agency,Department of Dentistry
[6] Winthrop University Hospital,Department of Dental Medicine
[7] The Ottawa Hospital Cancer Centre,Department of Nursing
[8] University of Copenhagen,Section of Oral Medicine, Clinical Oral Physiology, Oral Pathology & Anatomy, Department of Odontology, Faculty of Health and Medical Sciences
[9] Israel Defense Forces Medical Corps,Israeli Air Force Surgeon General Headquarters and Department of Oral Medicine
[10] Hebrew University-Hadassah School of Dental Medicine,Department of Oral Medicine
[11] University of Rochester Medical Center,Division of Oral Medicine, Eastman Institute for Oral Health
[12] University of Adelaide,School of Medical Sciences
[13] University of Connecticut Health Center,Section of Oral Medicine and Neag Comprehensive Cancer Center
来源：
Supportive Care in Cancer | 2013年 / 21卷
关键词：
Oral mucositis; Natural agents; Glutamine; Zinc; Guidelines;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3209 / 3221
页数：12
相关论文
共 337 条
[1]  
Keefe DM(2007)Updated clinical practice guidelines for the prevention and treatment of mucositis Cancer 109 820-831
[2]  
Schubert MM(2006)The role of alternative and natural agents, cryotherapy, and/or laser for management of alimentary mucositis Support Care Cancer 14 533-540
[3]  
Elting LS(2013)Methodology for the MASCC/ISOO Mucositis Clinical Practice Guidelines Update Support Care Cancer 21 303-308
[4]  
Sonis ST(2013)Development of the MASCC/ISOO Clinical Practice Guidelines for Mucositis: considerations underlying the process Support Care Cancer 21 309-312
[5]  
Epstein JB(1996)Rating the quality of evidence for clinical practice guidelines J Clin Epidemiol 49 749-754
[6]  
Raber-Durlacher JE(2000)ASCO clinical practice guidelines: process, progress, pitfalls, and prospects Class Pap Curr Comments 4 881-886
[7]  
Migliorati CA(1999)Phase III controlled evaluation of glutamine for decreasing stomatitis in patients receiving fluorouracil (5-FU)-based chemotherapy Am J Clin Oncol 22 258-261
[8]  
McGuire DB(2003)Glutamine-enriched parenteral nutrition after autologous peripheral blood stem cell transplantation: effects on immune reconstitution and mucositis Haematologica 88 192-200
[9]  
Hutchins RD(2008)The effect of glutamine supplementation on hematopoietic stem cell transplant outcome in children: a case–control study Pediatr Transplant 12 47-51
[10]  
Peterson DE(1994)Parenteral glutamine dipeptide supplementation does not ameliorate chemotherapy-induced toxicity Cancer 15 2879-2884
12345678910